Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
A practical introduction to Zero Based Budgeting, outlining why it works and how to start implementing it in your finances. Learn steps, tools, and best practices to optimize every dollar.
17,387 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Vertex is pursuing Crinetics with a substantial all-cash offer. This deep dive breaks down what the $10 billion bid m...
Analysts sometimes cut targets right before a big earnings release. This piece explains why that timing can mislead i...
Investors chasing SpaceX-style wins without a private bet must weigh public players carefully. This guide compares AS...
Over the last year, small-cap index funds have posted surprisingly strong returns. This article explains why that hap...
AMC Theatres recently blocked an award-winning AI short from its pre-show lineup, igniting a broader debate about AI,...
Magnite's 2025 earnings outlook centers on growing connected TV demand, platform efficiency, and navigating ad-tech p...
When a top executive at Yum China sells a large block of stock, investors pay attention. This article breaks down the...
A low-cost Emerging Markets ETF is quietly outperforming many active EM funds in 2026, raising questions about fees, ...
A viral Substack piece by a former EMT triggered rapid stock declines as AI fears spread. This article explains what ...
Oil jumps to $100 per barrel, sparking renewed interest in energy income strategies. This report breaks down XOMO, ML...
One AI stock sits at the intersection of great product momentum and misunderstood AI economics. This piece explains w...